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926Objective: Less invasive approaches to mitral valve surgery are increasingly used for improved cosmesis;
however, few studies have investigated their effect on outcome. We sought to compare these minimally invasive
approaches fairly with conventional full sternotomy by using propensity-matching methods.
Methods: From January 1995 to January 2004, 2124 patients underwent isolated mitral valve surgery through
a minimally invasive approach, and 1047 underwent isolated mitral valve surgery through a conventional sternot-
omy. Because there were important differences in patient characteristics, a propensity score based on 42 factors
was used to obtain 590 well-matched patient pairs (56% of cases).
Results: In-hospital mortality was similar for propensity-matched patients: 0.17% (1/590) for those undergoing
minimally invasive surgery and 0.85% (5/590) for those undergoing conventional surgery (P¼ .2). Occurrences
of stroke (P ¼ .8), renal failure (P>.9), myocardial infarction (P ¼ .7), and infection (P ¼ .8) were also similar.
However, 24-hour mediastinal drainage was less after minimally invasive surgery (median, 250 vs 350 mL;
P< .0001), and fewer patients received transfusions (30% vs 37%, P ¼ .01). More patients undergoing mini-
mally invasive surgery were extubated in the operating room (18% vs 5.7%, P<.0001), and postoperative forced
expiratory volume in 1 second was higher. Early after operation, pain scores were lower (P< .0001) after
minimally invasive surgery.
Conclusion:Within that portion of the spectrum of mitral valve surgery in which propensity matching was possi-
ble,minimally invasivemitral valve surgery had cosmetic, blood product use, respiratory, and pain advantages over
conventional surgery, andno apparent detriments.Mortality andmorbidity for robotic andpercutaneous procedures
should be compared with these minimally invasive outcomes. (J Thorac Cardiovasc Surg 2010;139:926-32)Supplemental material is available online.
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The Journal of Thoracic and Cardiovascular Surgimproving cosmesis; shortening hospital stay; and reducing
cost compared with the 50-year-old conventional median
sternotomy approach.1-8 Furthermore, it was believed that
less spreading of the incision, no interference with the dia-
phragm, and less tissue dissection might improve outcomes,
particularly respiratory function.7,8 Although clinical studies
suggest that some of these benefits have been realized, there
has been no confirmatory large study or randomized trial.1-10
Therefore, we performed a propensity-matched comparison
of short- and long-term outcomes in patients who underwent
minimally invasive mitral valve surgery with those who un-
derwent conventional full sternotomy.MATERIALS AND METHODS
Patients
From January 1995 to January 2004, 3171 patients underwent isolated
mitral valve surgery with or without tricuspid valve repair; patients under-
going concomitant aortic valve surgery, coronary artery bypass grafting,
or reoperation were excluded, as were those with endocarditis. The more re-
cently investigated approaches of right minithoracotomy and robotic proce-
dures were not included because they were included in the armamentarium
to treat mitral valve disease after this period. Aminimally invasive approach
was intended in 2124 (67%) patients, and conventional full medianery c April 2010
Abbreviations and Acronyms
CL ¼ asymmetric 68% confidence limits
FEV1 ¼ forced expiratory volume in 1 second
MR ¼ mitral regurgitation
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was 57  13 years (range, 18–89 years), and 58% were men.
Data were in part retrieved from the prospective Cardiovascular Informa-
tion Registry and in part from each patient’s medical record. These data
were approved for use in research by the institutional review board, with pa-
tient consent waived.
Surgical Technique
Conventional general anesthesia was used in all patients, regardless of
surgical approach. In those receiving a full median sternotomy, the mitral
valve was usually visualized through an incision in the left atrium anterior
to the right pulmonary veins. Patients who underwent minimally invasive
surgery had a 3- to 4-inch (8- to 10-cm) skin incision.1,3,7 Three minimally
invasive approaches were included in this study. From 1995 through 1996,
a right paramedian incision was used that included division of the third and
fourth costal cartilages (158 [8.4%] patients)1; from 1997 onward, this
changed to a J incision beginning at the sternal notch and ending at the
fourth intercostal space (1635 [87%] patients).7,8 From 1998 to 2004, 37
(1.8%) patients had a partial right lower sternotomy; choice of approach
was at the surgeon’s discretion. In this study, more recently introduced
approaches, such as robotic or lateral minithoracotomy, were added after
completion of the study.
With these minimally invasive chest-wall incisions, the mitral valve was
accessed through a transseptal incision. Routine mitral valve repair and re-
placement techniques were used, and all types of complete repairs were pos-
sible through the minimally invasive incision.1,8,10,11 Vacuum-assisted
cardiopulmonary bypass with central cannulation was used in all patients.12
Intraoperative transfusions, anesthetic technique, and timing of extubation
were at the anesthesiologist’s discretion. Intraoperative and postoperative
transfusion, extubation, and pain scores were not derived from protocols.
Clearly, in the early phase of this study, there was a learning curve involved
in developing the technique, which was, however, technically similar to
conventional sternotomy.
Study Design
A number of differences in patient characteristics precluded direct com-
parison of outcomes (Table 1). Therefore, to reduce the influence of selec-
tion, we used propensity matching to approximate a randomized trial.13-15
In the spirit of such a trial, we followed the intent-to-treat principle, such
that the 40 (1.9%) cases with an intended minimally invasive approach
who were converted to conventional sternotomy were retained in the mini-
mally invasive group. Initially, a parsimonious model based on variables in
Appendix 1 was formulated by means of logistic regression analysis with
bagging for variable selection (see Table E1) to understand the drivers of
patient selection.16 To this model were added nonsignificant variables to
form a propensity model. From this, a propensity score was generated for
each patient from a logistic regression model (C ¼ 0.86) based on 42 pre-
operative variables and procedure variables that were predictable preopera-
tively (Appendix 1). Greedy matching based on the propensity score was
used to identify 590 patient pairs for comparison (see Table E2).17 Figure 1
indicates the portion of the spectrum of propensity from which matched
pairs were obtained, and Table E2 documents characteristics of patients
for whom either minimally invasive or conventional approaches were
more heterogeneously applied during the study period. Clearly, as seen
from the figure, there is good overlap between the procedures after propen-The Journal of Thoracic and Casity adjustment. This strategy was repeated for the 2000–2004 cohort with
spirometric values and pain scores, yielding 268 propensity-matched patient
pairs.
Outcomes
Outcomes assessed included intraoperative support (myocardial ische-
mic and cardiopulmonary bypass times), postoperative in-hospital mortality
andmorbidity (defined in accordance with the Society of Thoracic Surgeons
National Database http://www.ctsnet.org/file/rptDataSpecifications252_1_
ForVendorsPGS.pdf), blood product use, mediastinal drainage at 6 and
24 hours, hematocrit value at hospital discharge, time to extubation
(which was at the discretion of attending anesthesiologists in either the
operating room or intensive care unit), all incentive spirometric values
after extubation, all pain scores, length of hospital stay, long-term
survival, and recurrence of mitral regurgitation (MR) in patients
undergoing repair.
Spirometry and pain scoring were performed and results were recorded
prospectively from January 2000 to January 2004, during which time 536
matched patients underwent operations. Both spirometric values and pain
scores were obtained routinely as part of clinical care from all patients after
surgical intervention. Spirometry, consisting of forced expiratory volume in
1 second ([FEV1] in milliliters), was performed periodically by respiratory
therapists using a Renaissance II bedside spirometer (Puritan Bennett, Carls-
bad, Calif) until hospital discharge; a total of 2234 values were available for
417 (78%) matched patients. FEV1 values were normalized to the percent-
age of predicted value by using the National Health and Nutrition Examina-
tion Survey algorithm.18 Pain intensity, ranging from 0 (none) to 10
(severe), was recorded by nursing staff from the patient’s arrival in the
intensive care unit to hospital discharge by using the extensively validated
Wong–Baker visual-analog scale.19,20 A total of 18,061 pain scores were
available for 454 (85%) matched patients.
Survival was assessed by follow-up every 2 years by using an institu-
tional review board–approved questionnaire supplemented by the Social Se-
curity Death Index.21,22 A total of 5296 patient-years of information was
available for analyses among matched patients, with a mean follow-up of
4.5  2.5 years; 25% of survivors were followed for more than 6.8 years,
and 10% were followed for more than 8 years. For matched patients under-
going minimally invasive surgery, 2787 patient-years of follow-up were
available for analyses, mean follow-up was 4.7  2.3 years, and 10%
were followed more than 7.9 years. For matched patients undergoing
conventional sternotomy, 2509 patient-years of follow-up were available
for analyses. Mean follow-up was 4.2 2.7 years, and 10% were followed
more than 8.4 years.
Recurrence of MR in patients undergoing repair was assessed by using
the transthoracic echocardiographic grade of postoperative MR. A total of
2039 postoperative echocardiograms were available for 816 matched pa-
tients undergoing repair (90% of total matched patients undergoing repair),
with a median follow-up of 1.3 months (minimum, 1 day; maximum, 14
years; Figure 2).
Comparisons
Categorical outcomes were compared by using either the c2 or Fisher’s
exact test, and continuous outcomes were compared by using the t test or
Wilcoxon rank-sum nonparametric test for skewed distributions. To com-
pare the temporal pattern of postoperative FEV1 across time, the repeated
continuous values were analyzed longitudinally by using mixed-model re-
gression,17 with autoregressive order 1 correlation structure to accommo-
date the correlated nature of the observations within each patient.
To compare the temporal pattern of postoperative pain across time, pain
scores were combined into 5 categories because of low frequency of higher
pain scores: 0 (pain score 0), 1 (pain scores 1–3), 2 (pain scores 4–6), 3 (pain
scores 7 and 8), and 4 (pain scores 9 and 10). Pain score category was ana-
lyzed longitudinally by using a nonlinear cumulative logit mixed model
for repeated measures that resolved a number of temporal components andrdiovascular Surgery c Volume 139, Number 4 927
TABLE 1. Patient characteristics and operative details by surgical approach: Overall
Minimally invasive (n ¼ 2124) Conventional (n ¼ 1047)
Variable No. % No. % P value
Demography
Female sex 805 38 522 50 <.0001
Age (y), mean  SD 56  13 59  14 <.0001
BMI (kg$m2), mean  SD 26  4.0 27  5.4 <.0001
NYHA functional class <.0001
I 588 28 146 14
II 1,234 58 560 53
III 251 12 260 25
IV 51 2.4 81 7.7
Indication for operation
Degenerative 1803 85 622/1046* 59 <.0001
Ischemic 12 0.56 36/1046* 3.4 <.0001
Rheumatic 196 9.2 201/1046* 19 <.0001
Other 113 5.3 187/1046* 18 <.0001
Cardiac comorbidity
LV dysfunction 107/2038* 5.2 209/944* 22 <.0001
Tricuspid regurgitation>moderate 177/2062* 8.6 181/837* 22 <.0001
Atrial fibrillation/flutter 240 11 186 18 <.0001
Noncardiac comorbidity
Hypertension 733/2073* 35 449/967* 46 <.0001
Treated diabetes 33/2077* 1.6 75/997* 7.5 <.0001
COPD 255/2022* 13 224/702* 32 <.0001
Procedure
Mitral valve repair 1916 90 747 71 <.0001
Tricuspid valve repair 129 6.1 191 18 <.0001
SD, Standard deviation; BMI, body mass index; NYHA, New York Heart Association; LV, left ventricular; COPD, chronic obstructive pulmonary disease. *Number of patients with
data available.
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by a time function with common random intercept. Survival was compared
nonparametrically by using theKaplan–Meiermethod and parametrically by
using a temporal decomposition model.23 To compare temporal pattern of
postoperative MR across time, we have used a nonlinear cumulative logit
mixed model, as described above. Because of low frequency, MR grades
3þand 4þwere collapsed together and treated as one category.
Presentation
Categorical variables are summarized as frequencies and percentages
and continuous variables as means  standard deviations or as equivalent
15th, 50th (median), and 85th percentiles (for consistency with1 standard
deviation) when data were skewed. Asymmetric 68% confidence limits
(CLs) are consistent with 1 standard error. All analyses were performed
with SAS statistical software version 9.1 (SAS Institute, Inc, Cary, NC).RESULTS
Intraoperative Support
Among propensity-matched patients, ischemic time was
slightly longer after a minimally invasive approach (65 
24vs 62 23minutes,P¼ .01), and cardiopulmonary bypass
time was equivalent (85  46 vs 84  31 minutes, P ¼ .9).In-hospital Mortality and Morbidity
In-hospital mortality was 0.17% (CL, 0.03%–0.56%) in
the minimally invasive group and 0.85% (CL, 0.48%–928 The Journal of Thoracic and Cardiovascular Surg1.4%) in the matched conventional group (P¼ .2, Table 2).
In-hospital complications occurred with similar frequency in
matched groups (Table 2).
Bleeding and Transfusion
Return to the operating room for bleeding was similar in
matched groups (Table 2); however, mediastinal drainage
was lower at 6 and 24 hours after a minimally invasive ap-
proach (100 mL [CL, 50–200 mL] and 250 mL [CL, 150–
350 mL]) than after conventional sternotomy (150 mL
[CL, 100–300 mL] and 350 mL [CL, 250–600 mL]) at these
times (P< .0001). Transfusion was less frequent after min-
imally invasive surgery than after conventional surgery
(Table 2). However, hematocrit values at discharge were
slightly lower after minimally invasive surgery (30% 
3.5% vs 31%  3.7%, P< .0001).
Respiratory Function
A higher proportion of matched patients were extubated
in the operating room after minimally invasive than conven-
tional surgery (18% vs 5.7%, P< .0001). Median hours to
extubation were also shorter (4.8 hours [CL, 2.2–10 hours]
vs 5.6 hours [CL, 3.0–14 hours], P ¼ .001). FEV1 was sim-
ilar immediately after extubation; however, it remainedery c April 2010
FIGURE 1. Mirrored histogram of distribution of propensity scores for
conventional (bars above zero line) and minimally invasive (bars below
zero line) approaches. The darkened area represents matched patient pairs,
showing that they cover the complete spectrum of cases. MIP, Minimally
invasive valve surgery.
FIGURE 2. Number of patients with echocardiograms available at and be-
yond various time points and number of echocardiograms available for
analysis. Black bars, echocardiograms; gray bars, patients.
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the conventional sternotomy group during the first 12 hours
and increased thereafter (Figure 3).
Postoperative Pain
The general temporal pattern of pain score categories is il-
lustrated in Figure 4, A. Over the first 24 postoperative
hours, only about a third of patients were pain free, and
this proportion increased to about 60% by day 3 and stabi-
lized. Matched patients undergoing minimally invasive sur-
gery had less pain in the first 24 hours after the operation
(P< .0001) but similar pain scores thereafter (Figure 4, B).
Length of Stay
Among matched patients, median postoperative length of
stay was 6 days (CL, 4–10 days) after minimally invasive
surgery and, similarly, 6 days (CL, 5–10 days) after conven-
tional sternotomy (P ¼ .3).
Survival
Survival at 1, 5, and 8 years was 98%, 91%, and 86% af-
ter minimally invasive surgery and 96%, 89%, and 84% af-
ter conventional surgery among matched patients (P ¼ .07,
Figure 5).
Return of Mitral Valve Regurgitation After Repair
Proportions of patients in MR grade 3þ or 4þ at 1 and 5
years were 4% and 5% after minimally invasive surgeryThe Journal of Thoracic and Caand 6% and 7% after conventional surgery among matched
patients (P> .1, Figure 6).DISCUSSION
Patients are increasingly requesting less invasive mitral
valve procedures. In an attempt to achieve this and also
maintain or improve on results of full median sternotomy,
we pioneered the approach of paramedian or J incision par-
tial sternotomies.1,7 Other minimally invasive and endo-
scopic approaches were also pioneered.2-6
When minimally invasive cardiac surgery was introduced
in the 1990s, concern centered around longer operations,
greater risk, and more complications for the perceived ben-
efit of better cosmetic results, better respiratory function, and
less pain and bleeding. Some approaches became less fre-
quently used because of problems, such as with the parame-
dian incision, peripheral cannulation for cardiopulmonary
bypass, and robotic surgery.1-10,24 Others, such as endo-
scopic or partial sternotomy, particularly the J incision,
have become more widely adopted.1-10Principal Findings
This study confirms the previously unproved perception
that there are no disadvantages to minimally invasive sur-
gery; that is, procedure time is not lengthened, risks are com-
parable or less, transfusions are less frequent, respiratory
function is better, early postoperative pain is less, length
of stay is comparable or shorter, long-term survival is com-
parable, and return of MR is uncommon and similar. Al-
though there was no major difference in survival, it should
be noted that hospital and 30-day survival was greater
than 99% in both groups, and thus to show a difference in
early postoperative risk would require a huge number ofrdiovascular Surgery c Volume 139, Number 4 929
TABLE 2. In-hospital outcomes by surgical approach both overall and in propensity-matched patients
Overall Propensity-Matched
Minimally invasive
(n ¼ 2124)
Conventional
(n ¼ 1047)
Minimally invasive
(n ¼ 590)
Conventional
(n ¼ 590)
Outcome No. % No. % P value No. % No. % P value
Death 4 0.19 19 1.8 <.0001 1 0.17 5 0.85 .2
Stroke 33 1.6 17 1.6 .9 7 1.2 6 1.0 .8
Renal failure 5 0.24 14 1.3 .0002 4 0.68 5 0.85 >.9
Myocardial infarction 9 0.42 4 0.38 .9 4 0.68 2 0.34 .7
Deep sternal wound infection 14 0.66 4 0.38 .3 6 1.02 4 0.68 .8
Sepsis/septicemia 17 0.8 31 3.0 <.0001 8 1.4 12 2.0 .4
Return to OR for bleeding 64 3.0 46 4.4 .04 20 3.4 26 4.4 .4
RBC transfusion 315/2022* 16 405/803* 50 <.0001 155/517* 30 184/500* 37 .01
Respiratory failure 42 2.0 61 5.8 <.0001 20 3.4 19 3.2 .9
OR, Operating room; RBC, red blood cell. *Number of patients with data available.
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Dpatients. Hence early and late operative results were not
compromised.
Less perioperative bleeding and fewer blood transfusions
are likely due to the less extensive mediastinal dissection re-
quired for the minimally invasive approach. Less pain is
likely related to less surgical dissection, less spreading of
the sternum, and no escalation of tension on the posterior
rib head and costovertebral ligaments because the chest
wall is not opened like a trap door. The better pulmonary
function can be explained by no interference with the dia-
phragm or dissection along it. Also, with less chest wall
pain, patients might have less splinting of the chest and
thus can breathe more deeply.
Considerable interest has been directed recently toward
percutaneous valves, including mitral valve coronary sinus–
based devices or innovative leaflet approximation technolo-FIGURE 3. Temporal pattern of postextubation forced expiratory volume
in 1 second (FEV1) as a percentage of predicted value after minimally
invasive (MIP) and conventional mitral valve surgery among propensity-
matched patients. Solid lines are parametric estimates of temporal trend en-
closed within dashed lines representing 68% confidence limits (equivalent
to 1 standard error). Symbols represent data grouped within time frames
without regard for repeated assessment simply to provide crude verification
of model fit. NHANES, National Health and Nutrition Examination Survey.
930 The Journal of Thoracic and Cardiovascular Surggies.25-30Mortality andmorbidity results reported in this study
should serve as a benchmark against which forthcoming per-
cutaneous valve results are compared in otherwise good surgi-
cal candidates. Mortality of less than 1% and even 0.2% toFIGURE 4. Temporal pattern of pain score categories after minimally in-
vasive versus conventional mitral valve surgery among propensity-matched
patients. Symbols represent data grouped within time frames without regard
for repeated assessment simply to provide crude verification of model fit.
Solid lines are parametric estimates of the percentage of patients in each cat-
egory. A, All pain score categories. B, Proportion of patients without pain
(category 0).
ery c April 2010
FIGURE 5. Survival after minimally invasive (MIP) and conventional mi-
tral valve surgery among propensity-matched patients. Each symbol repre-
sents a death, positioned actuarially; vertical bars represent 68%
confidence limits; and numbers in parentheses represent patients remaining
at risk. Solid lines are parametric estimates enclosedwithin dashed lines rep-
resenting 68% confidence limits (equivalent to 1 standard error).
FIGURE 6. Proportion of patients with mitral regurgitation (MR) grade 3þ
or 4þ after minimally invasive (MIP) and conventional mitral valve repair
among propensity-matched patients. Symbols represent data grouped within
time frame without regard for repeated assessment simply to provide crude
verification of model fit. Solid lines are parametric estimates of the percent-
age of patients in MR grade 3þ or 4þ enclosed within 68% bootstrap
percentile confidence limits.
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as stroke occurrence of less than 1.7%. Furthermore, aswe re-
ported previously, all patients should have 1þor lessMR after
mitral valve repair.31-33 Whether percutaneous devices will
convey a cost benefit, less pain, and shorter hospital stay
over minimally invasive approaches remains to be seen, par-
ticularly with the likely higher costs of these devices. Since
the closing date of this study (January 2006), we have increas-
ingly used right minithoracotomy and robotic approaches.
Indeed, currently, one quarter of our patients receive a conven-
tional open approach, one quarter receive a mini-J incision,
one quarter receive a minithoracotomy, and one quarter re-
ceive robotic surgery.We are currently conducting a prospec-
tive study to compare these approaches.
Limitations
Although heterogeneity in the use of minimally invasive
mitral valve surgery provided the opportunity for compari-
sons with conventional surgery, clearly, as a group, patients
undergoing conventional mitral valve surgery were sicker,
with a less favorable prognosis (Figures E1–E3), than those
undergoing minimally invasive surgery. When a propensity
score was used to match patients, the comparison groups
were intermediate in risk, and differences in most outcomes
appeared to be explained by differences in patient character-
istics rather than surgical approach. Indeed, like randomized
trials that address only that portion of the spectrum of disease
for which equipoise is present, propensity methods address
only that portion of the spectrum for which heterogeneity
in practice is discovered. However, as shown in Figure 1,
matched patients cover the entire spectrum of propensity
scores, although at both extremes of the spectrum, surgeons
at Cleveland Clinic during the period of this study tended to
use predominantly a minimally invasive or a conventional
approach. Factors driving this decision are identified inThe Journal of Thoracic and CaTable 1: obesity, cerebral vascular disease, left ventricular
function, acuity, cause of disease, tricuspid valve regurgita-
tion, era of operation, and intent to repair rather than replace
the valve. We acknowledge that selection bias cannot be
completely reversed by using propensity-based methods
and, in this study, cannot completely overcome distinct sur-
geon preferences. Because treatment was not masked, pa-
tients’ self-reporting of pain scores might have been biased
as well. This is also a single-institution study, which limits
its generalizability. Nevertheless, timing to extubation, spi-
rometric values, and pain scores would largely have been un-
influenced by potential surgeon biases because these were
determined or routinely collected by respiratory therapists,
anesthesiologists, or nurses.CONCLUSION
Minimally invasive mitral valve surgery has cosmetic,
blood product use, respiratory, and pain advantages and no
apparent detriments. We routinely use the approach for
most complex mitral valve procedures, excluding those re-
quiring additional procedures, such as coronary artery or
aortic surgery. For patients with localized P2-related regur-
gitation, we tend to perform valve repair using a robotic ap-
proach. We are, however, prospectively evaluating the
options of a right minimally invasive thoracotomy and
robotic approaches.References
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FIGURE E1. Temporal pattern of postextubation forced expiratory vol-
ume in 1 second (FEV1) as a percentage of predicted value after minimally
invasive (MIP) and conventional mitral valve surgery among all patients.
Solid lines are parametric estimates of temporal trend enclosed within
dashed lines representing 68% confidence limits (equivalent to1 standard
error). Symbols represent data grouped within time frames without regard
for repeated assessment simply to provide crude verification of model fit.
NHANES, National Health and Nutrition Examination Survey.
FIGUREE2. Temporal pattern of pain score categories after minimally in-
vasive versus conventional mitral valve surgery among all patients. Symbols
represent data grouped within time frames without regard for repeated as-
sessment simply to provide crude verification of model fit. Solid lines are
parametric estimates of the percentage of patients in each category.
FIGURE E3. Survival after minimally invasive (MIP) and conventional
mitral valve surgery among all patients. Each symbol represents a death, po-
sitioned actuarially; vertical bars represent 68% confidence limits; and
numbers in parentheses represent patients remaining at risk. Solid lines
are parametric estimates enclosed within dashed lines representing 68%
confidence limits (equivalent to 1 standard error).
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TABLE E1. Parsimonious model of factors associated with the minimally invasive versus conventional approach for mitral valve surgery*
Factor Coefficient ± SD P value Reliability (%)y
Higher likelihood of conventional approach
Larger BMIz 1.9  0.28 <.0001 99
Carotid disease 0.80  0.16 <.0001 48
Greater LV dysfunction 0.52  0.054 <.0001 99
Higher NYHA functional classx 0.61  0.14 <.0001 90
Tricuspid valve repair 0.88  0.15 <.0001 60
Earlier date of operationjj 3.5  0.21 <.0001 100
Higher likelihood of minimally invasive approach
MV repair 1.02  0.13 <.0001 98
Degenerative MV etiology 0.33  0.12 .007 89
SD, Standard deviation; BMI, body mass index; LV, left ventricular; NYHA, New York Heart Association;MV, mitral valve. *Obtained by means of logistic regression with variable
selection by bagging.16 yFrequency of occurrence in 1000 bootstrap models. zBMI2, squared transformation. xLn(NYHA functional class), logarithmic transformation.
jjLn(interval from January 1, 1995, to date of operation), logarithmic transformation.
TABLE E2. Patient characteristics and operative details by surgical approach: Propensity-matched pairs
Propensity matched Unmatched
Minimally invasive
(n ¼ 590)
Conventional
(n ¼ 590)
Minimally invasive
(n ¼ 1534)
Conventional
(n ¼ 457)
Variable No. % No. % P value No. % No. % P value
Demography
Female sex 276 47 267 45 .6 529 34 255 56 <.0001
Age (y), mean  SD 59  13 59  14 .6 55  13 60  17 <.0001
BMI (kg$m2), mean  SD 26  4.8 26  5.3 .9 25  3.7 27  5.4 <.0001
NYHA functional class .7 <.0001
I 99 17 94 16 489 32 52 11
II 350 59 352 60 884 58 208 46
III 114 19 123 21 137 8.9 137 30
IV 27 4.6 21 3.6 24 1.6 60 13
Indication for operation
Degenerative 403 68 414/589* 70 .5 1400 91 208 46 <.0001
Rheumatic 98 17 89/589* 15 .5 98 6.4 112 25 <.0001
Ischemic 11 1.9 13/589* 2.2 .7 1 0.07 23 5.03 <.0001
Other 78 13 73/589* 12 .7 35 2.3 114 25 <.0001
Cardiac comorbidity
LV dysfunction 68/556* 12 66/548* 12 .6 39/1482* 2.6 143/396* 34 <.0001
Tricuspid regurgitation>moderate 84/532* 16 80/525* 15 >.9 93/1530* 6.1 101/312* 32 <.0001
Atrial fibrillation/flutter 101 17 99 17 .9 139 9.1 87 19 <.0001
Noncardiac comorbidity
Hypertension 246/575* 43 235/552* 42 >.9 487/1498* 33 214/415* 52 <.0001
Treated diabetes 23/562* 4.1 25/568* 4.4 .8 10/1515* 0.66 50/429* 12 <.0001
COPD 106/493* 22 113/487* 23 .5 149/1529* 9.7 111/215* 52 <.0001
Procedure
Mitral valve repair 453 77 452 77 .9 1463 95 295 65 <.0001
Tricuspid valve repair 78 13 73 12 .7 51 3.3 118 26 <.0001
SD, Standard deviation; BMI, body mass index; NYHA, New York Heart Association; LV, left ventricular; COPD, chronic obstructive pulmonary disease. *Number of patients with
data available.
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